The seminar was organized by the Department of Public Health of the Warsaw Medical University in cooperation with the Institute of Health Care on October 25. During the discussion moderated by Prof. Mariusz Gujski, head of the Department of Public Health at the Faculty of Health Sciences of the Warsaw University of Medical Sciences, experts pointed out the directions of development of robotics in medicine.
22 years of Da Vinci in Poland
Artur Ostrowski, managing director of Synektik, presented the development of the Da Vinci robotic surgery market worldwide. By 2022, 3,000 scientific publications on Da Vinci had been written, 4,200 technologies used by the robot had been patented, and 10 million procedures had been performed using it.
Today, there are already 8285 Da Vinci systems in use worldwide, with 65% in the US, 17% in Europe and 13% in Asia. Robotics is used primarily in urology, colorectal surgery, bariatric surgery, gynecological oncology, but also in orthopedics.
Artur Ostrowski recalled that the first such device came to Poland in 2011, and it was already a third-generation robot. In 2017. AOTMiT issued a positive recommendation for the use of Da Vinci in the treatment of bowel, prostate and uterine cancers, but not until 2022. The National Health Fund began reimbursing radical robotic prostatectomy. According to Artur Ostrowski, NFZ reimbursement plays an important role in the development of robotic surgery in Poland. He pointed out that although the procedures are not cheap, the use of Da Vinci avoids complications and reduces the number of in-hospital infections, which can reimburse the cost of maintaining the robot.
He pointed out that there is a circulating opinion that there are too many robots in Poland. - This is not true. The largest number is used in France - 340, in Germany - 330 , in the UK - 200, in Italy 195, and in Spain more than 105. Mean...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
